94191-12-5

Usage

Uses

Used in Pharmaceutical and Agrochemical Development:
3-Bromothiopheno[3,2-b]pyridine serves as a valuable building block in organic synthesis, particularly for the creation of new pharmaceuticals and agrochemicals. Its unique structure allows for the development of compounds with potential therapeutic and pesticidal properties, contributing to advancements in healthcare and agriculture.
Used in Antimicrobial and Anti-Fungal Applications:
This chemical compound has been studied for its potential biological activities, including antimicrobial and anti-fungal properties. 3-Bromothiopheno[3,2-b]pyridine can be utilized in the formulation of antimicrobial agents to combat bacterial and fungal infections, offering new solutions for infectious disease treatment and prevention.
Used in Materials Science:
3-Bromothiopheno[3,2-b]pyridine has also been explored for its applications in materials science. It has been considered for use in the development of organic semiconductors and liquid crystals, which are crucial components in various electronic devices and display technologies. Its incorporation into these materials can enhance their performance and contribute to the advancement of the electronics and optoelectronics industries.
Overall, 3-bromothiopheno[3,2-b]pyridine is a versatile chemical compound with a wide range of applications in pharmaceuticals, agrochemicals, antimicrobial and anti-fungal agents, and materials science. Its unique structure and properties make it a promising candidate for further research and development in these fields.

InChI:InChI=1/C7H4BrNS/c8-5-4-10-6-2-1-3-9-7(5)6/h1-4H

Upstream product

• 272-67-3 thieno[3,2-b]pyridine 
• 40925-53-9 benzyl 2-(2-pyridyl)vinyl sulfide 
• 69627-03-8 7-chlorothieno[3,2-b]pyridine 
• 603305-89-1 7-bromothieno[3,2-b]pyridine 
• 69627-02-7 thieno[3,2-b]pyridin-7-ol 

Relevant academic research and scientific papers

2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(amino-oxo-aryl-λ6- sulfanylidene)acetamide compounds (referred to herein as ANASIA compounds) that, inter alia, inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase (aaRS) (e.g., bacterial leucyl-tRNA synthetase, LeuRS). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase; to treat disorders that are ameliorated by the inhibition (e.g., selective inhibition) of bacterial aminoacyl-tRNA synthetase; to treat bacterial infections; etc.

THIOPHENE PYRAZOLOPYRIMIDINE COMPOUNDS

The present invention relates to compounds of Formula (I), pharmaceutical compositions thereof, and the use of such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric and neuroendocrine disorders, neurological diseases, and metabolic syndrome.

IMIDAZOPYRIDAZINE COMPOUNDS

The present invention relates to novel substituted imidazo[1,2-b] pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.

Chemistry of Thienopyridines. XXXI. A New Synthesis of Thienopyridine and Studies on Direct Substitution into Its Thiophene Ring

Thienopyridine (1) is synthesized in 65percent overall yield for two steps which consist of addition of toluene-α-thiol to 2-ethynylpyridine plus vacuum pyrolysis of the addend (7).Cis and trans forms of 7 are described.Compound 1 undergoes (a) ele